找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Diabetes Management in Hospitalized Patients; A Comprehensive Clin Rifka C. Schulman-Rosenbaum Book 2023 The Editor(s) (if applicable) and

[復(fù)制鏈接]
樓主: JOLT
11#
發(fā)表于 2025-3-23 12:59:20 | 只看該作者
12#
發(fā)表于 2025-3-23 16:54:43 | 只看該作者
Cystic Fibrosis-related Diabetesicians may encounter CFRD in the setting of acute illness in people with CF, highlighting the importance of understanding this CF complexity. In this chapter, we review the pathophysiology, diagnosis, management strategies, and outcomes of CFRD, with an additional focus on inpatient diagnosis and management of CFRD.
13#
發(fā)表于 2025-3-23 18:57:42 | 只看該作者
York Sure,Steffen Staab,Rudi Studer surgery services. This chapter provides insight into inpatient diabetes epidemiology, reviews the pivotal studies of inpatient diabetes management, outlines the history of major diabetes guidelines, describes specialized hospital-based diabetes teams, and summarizes the history and future of diabetes technology.
14#
發(fā)表于 2025-3-23 22:40:45 | 只看該作者
An Ontology-Composition Algebraon-insulin therapies in select patients, form the core of inpatient pharmacologic treatment of hyperglycemia. This chapter reviews the current standards of inpatient care for the noncritically ill patient with type 2 diabetes mellitus and/or hyperglycemia.
15#
發(fā)表于 2025-3-24 05:12:34 | 只看該作者
Ontology Engineering Environments180?mg/dL, with insulin as the preferred modality of treatment. Little data is available on the management of hyperglycemia in special populations such as patients with renal failure or congestive heart failure.
16#
發(fā)表于 2025-3-24 07:49:19 | 只看該作者
17#
發(fā)表于 2025-3-24 11:31:43 | 只看該作者
18#
發(fā)表于 2025-3-24 18:29:38 | 只看該作者
19#
發(fā)表于 2025-3-24 22:32:23 | 只看該作者
Current Standards of Care for Inpatient Type 2 Diabetes Mellituson-insulin therapies in select patients, form the core of inpatient pharmacologic treatment of hyperglycemia. This chapter reviews the current standards of inpatient care for the noncritically ill patient with type 2 diabetes mellitus and/or hyperglycemia.
20#
發(fā)表于 2025-3-25 02:37:24 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 15:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
平安县| 麟游县| 山西省| 犍为县| 安阳县| 武功县| 平遥县| 门头沟区| 无为县| 离岛区| 平阳县| 永仁县| 清徐县| 鸡西市| 岑巩县| 喀喇沁旗| 宜宾县| 贺兰县| 鹿泉市| 太湖县| 嘉禾县| 陆丰市| 鹤庆县| 马山县| 吐鲁番市| 双城市| 固始县| 万山特区| 门源| 平陆县| 丰台区| 吕梁市| 茶陵县| 东山县| 西峡县| 永新县| 乐平市| 香河县| 若尔盖县| 定兴县| 武功县|